Paclitaxel-Trastuzumab Mixed Nanovehicle to Target HER2-Overexpressing Tumors

by Celia Nieto, Ariana Centa, Jesús A. Rodríguez-Rodríguez, Atanasio Pandiella, Eva M. Martín del Valle
Published 2019-06-01